Clinical Supply Planning Resources

  1. Cell & Gene Therapy Supply Chain Challenges: Global, Integrated Solutions

    Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

  2. FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study 3/12/2026

    Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.

  3. GxP Inventory Delivers Real-Time Visibility, Operational Efficiency 11/17/2025

    Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.

  4. Clinical Supply Distribution Strategy – Planning & Adapting 11/18/2022

    Discover how to ensure your distribution plan is robust, how to best determine your depot requirements, how to efficiently adapt to study changes, as well as how COVID may impact your distribution planning.

  5. Planning For The Return And Destruction Of Your Product 8/24/2022

    Aspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.

  6. Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting 11/17/2025

    Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.

  7. Site-Centric Clinical Supply Strategy Optimization 1/14/2022

    Learn about supply strategy optimization while balancing the importance of remaining site-centric in this webinar.

  8. Safely Transporting Medicines To Patients

    Do pharma companies underestimate supply chain challenges? Much can go wrong when sending a therapy from A to B, but the right collaborations can mitigate risk.

  9. Overcoming Cell Therapy Supply Chain Challenges 5/11/2021

    For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.

  10. Essential Up-Front Planning For Your Clinical Trial

    Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.